You are here: Home » News-CM » Companies » News
Business Standard

Dr Reddy's Laboratories launches Neostigmine Methylsulfate Injection in U.S.

Capital Market 

announced the launch of Methylsulfate Injection, USP, a therapeutic equivalent generic version of Bloxiverz (Methylsulfate) Injection approved by the U. S. (USFDA).

The Bloxiverz brand and generic had U.

S. sales of approximately $111 million MAT for the most recent twelve months ending in July 2018 according to IMS

Dr. Reddy's Methylsulfate Injection, USP is available in 5 mg/10 ml and 10 mg/10 ml multi-dose vials

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Wed, September 12 2018. 17:35 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU